Monaco Health（Harahan, LA）

Monaco Health operates in Harahan, Louisiana, under the medical direction of Dr. Michael J. Straney, a board-certified Emergency Medicine physician who holds diplomate status with the American Board of Obesity Medicine. This dual certification positions the clinic to address acute metabolic concerns alongside chronic weight management and hormonal optimization. Dr. Straney’s emergency medicine background informs a clinical approach that prioritizes patient safety, rapid assessment, and evidence-based intervention protocols adapted to the outpatient regenerative medicine setting. The clinic serves patients throughout the greater New Orleans metropolitan area seeking medical weight loss and hormone restoration therapies grounded in physician oversight.

The clinic’s peptide therapy program centers on Sermorelin, a growth hormone-releasing hormone analog consisting of the first 29 amino acids of naturally occurring GHRH. Sermorelin stimulates the pituitary gland to produce endogenous growth hormone in a physiologic pattern, supporting improved body composition, sleep architecture, and metabolic function without the supraphysiologic spikes associated with exogenous growth hormone administration. Monaco Health integrates Sermorelin into comprehensive treatment plans that may include GLP-1 receptor agonist medications for appetite regulation and glycemic control, as well as testosterone replacement therapy for patients with clinically diagnosed hypogonadism. Each peptide protocol is dosed individually based on patient response, laboratory markers, and treatment goals, with ongoing monitoring to adjust therapy as metabolic parameters shift.

Dr. Straney’s obesity medicine diplomate credential reflects advanced training in the pathophysiology of adiposity, pharmacotherapy for weight reduction, and behavioral modification strategies. This expertise allows Monaco Health to offer structured weight loss programs that address insulin resistance, leptin signaling dysfunction, and neuroendocrine factors contributing to weight regain. Hormone therapy services extend beyond testosterone replacement to include thyroid optimization and assessment of cortisol dysregulation, recognizing that successful metabolic outcomes require addressing multiple endocrine axes simultaneously. The clinic’s diagnostic process includes comprehensive lab panels evaluating lipid metabolism, inflammatory markers, and hormone levels before initiating any peptide or hormone intervention.

Patients at Monaco Health receive in-person consultations at the Harahan location, allowing for direct physical examination, body composition analysis, and face-to-face discussion of treatment options and realistic outcome expectations. Initial visits typically involve detailed medical history review, assessment of previous weight loss attempts or hormone therapy trials, and discussion of lifestyle factors affecting metabolic health. Follow-up appointments track progress through objective measures including weight trends, waist circumference changes, laboratory value improvements, and patient-reported outcomes related to energy, sleep quality, and physical performance. The clinic structures treatment plans in defined phases, with clear milestones for reassessing peptide dosing, adjusting ancillary medications, and determining appropriate therapy duration based on individual response patterns.

Monaco Health’s location in Harahan provides accessible care for residents of Jefferson Parish and surrounding New Orleans communities seeking alternatives to conventional weight management approaches that have proven insufficient. The clinic’s integration of peptide therapy, GLP-1 medications, and testosterone replacement under a single provider allows for coordinated treatment adjustments as patients progress through different phases of metabolic restoration. Dr. Straney’s emergency medicine training contributes to thorough screening for contraindications and vigilant monitoring for adverse effects, ensuring that regenerative therapies are delivered with appropriate medical safeguards. The practice maintains a patient-centered model where treatment intensity and medication selection align with individual tolerance, lifestyle constraints, and long-term sustainability rather than pursuing aggressive protocols that compromise adherence or safety.